...
首页> 外文期刊>Angewandte Chemie >A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
【24h】

A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers

机译:癌症激活化疗和光动力疗法结合抗癌癌的多作用和多目标ruii-PTIV缀合物

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract > Pt II complexes are commonly used to treat cancer. To reduce their side effects and improve their pharmacological properties, Pt IV complexes are being developed as prodrug candidates that are activated by reduction in cancer cells. Concomitantly, Ru II polypyridine complexes have gained much attention as photosensitizers for use in photodynamic therapy due to their attractive characteristics. In this article, a novel Pt IV –Ru II conjugate, which combines cancer activated chemotherapy with PDT, is presented. Upon entering the cancer cell, the Pt IV centre is reduced to Pt II and the axial ligands including the Ru II complex and phenylbutyrate are released. As each component has its individual targets, the conjugate exerts a multi‐target and multi‐action effect with (photo‐)cytotoxicity values upon irradiation up to 595?nm in the low nanomolar range in various (drug resistant) 2D monolayer cancer cells and 3D multicellular tumour spheroids. </abstract> </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> <div class="translation abstracttxt"> <span class="zhankaihshouqi fivelineshidden" id="abstract"> <span>机译:</span><Abstract Type =“Main”XML:Lang =“en”> <标题类型=“main”>抽象</ title> > Pt. ii </ sup> 复合物通常用于治疗癌症。减少副作用,改善其药理学特性,PT iv </ sup> 复合物正在开发成通过减少癌细胞激活的前药候选。克服,ru ii </ sup> 由于其有吸引力的特性,聚吡啶络合物作为光敏剂的光敏剂效应了很多。在本文中,一个小说PT iv </ sup> -ru. ii </ sup> 提出了将癌症活化化疗与PDT结合的缀合物。进入癌细胞后,PT iv </ sup> 中心减少到PT ii </ sup> 和包括ru的轴向配体 ii </ sup> 释放复合物和苯基丁酸酯。当每个组分具有其个体靶标时,缀合物在低至595μm在不同(耐药性)2D单层癌细胞和3D多细胞肿瘤球形。 </ p> </摘要> </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> </div> <div class="record"> <h2 class="all_title" id="enpatent33" >著录项</h2> <ul> <li> <span class="lefttit">来源</span> <div style="width: 86%;vertical-align: text-top;display: inline-block;"> <a href='/journal-foreign-19011/'>《Angewandte Chemie》</a> <b style="margin: 0 2px;">|</b><span>2020年第18期</span><b style="margin: 0 2px;">|</b><span>共7页</span> </div> </li> <li> <div class="author"> <span class="lefttit">作者</span> <p id="fAuthorthree" class="threelineshidden zhankaihshouqi"> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Karges Johannes&option=202" target="_blank" rel="nofollow">Karges Johannes;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Yempala Thirumal&option=202" target="_blank" rel="nofollow">Yempala Thirumal;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Tharaud Micka?l&option=202" target="_blank" rel="nofollow">Tharaud Micka?l;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Gibson Dan&option=202" target="_blank" rel="nofollow">Gibson Dan;</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Gasser Gilles&option=202" target="_blank" rel="nofollow">Gasser Gilles;</a> </p> <span class="z_kbtnclass z_kbtnclassall hoverxs" id="zkzz" style="display: none;">展开▼</span> </div> </li> <li> <div style="display: flex;"> <span class="lefttit">作者单位</span> <div style="position: relative;margin-left: 3px;max-width: 639px;"> <div class="threelineshidden zhankaihshouqi" id="fOrgthree"> <p>Chimie ParisTechPSL University75005 Paris France;</p> <p>Institute for Drug ResearchThe Hebrew University of Jerusalem91120 Jerusalem Israel;</p> <p>Institut de Physique du Globe de ParisUniversité de Paris75005 Paris France;</p> <p>Institute for Drug ResearchThe Hebrew University of Jerusalem91120 Jerusalem Israel;</p> <p>Chimie ParisTechPSL University75005 Paris France;</p> </div> <span class="z_kbtnclass z_kbtnclassall hoverxs" id="zhdw" style="display: none;">展开▼</span> </div> </div> </li> <li > <span class="lefttit">收录信息</span> <span style="width: 86%;vertical-align: text-top;display: inline-block;"></span> </li> <li> <span class="lefttit">原文格式</span> <span>PDF</span> </li> <li> <span class="lefttit">正文语种</span> <span>eng</span> </li> <li> <span class="lefttit">中图分类</span> <span><a href="https://www.zhangqiaokeyan.com/clc/1188.html" title="应用化学">应用化学;</a></span> </li> <li class="antistop"> <span class="lefttit">关键词</span> <p style="width: 86%;vertical-align: text-top;"> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=bioinorganic chemistry&option=203" rel="nofollow">bioinorganic chemistry;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=metals in medicine&option=203" rel="nofollow">metals in medicine;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=photodynamic therapy&option=203" rel="nofollow">photodynamic therapy;</a> <a style="color: #3E7FEB;" href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=platinum prodrugs&option=203" rel="nofollow">platinum prodrugs;</a> </p> <div class="translation"> 机译:生物有机化学;医学中的金属;光动力疗法;铂前药; </div> </li> </ul> </div> </div> <div class="literature cardcommon"> <div class="similarity "> <h3 class="all_title" id="enpatent66">相似文献</h3> <div class="similaritytab clearfix"> <ul> <li class="active" >外文文献</li> <li >中文文献</li> <li >专利</li> </ul> </div> <div class="similarity_details"> <ul > <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704028160783.html">A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Karges Johannes&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Karges Johannes,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Yempala Thirumal&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Yempala Thirumal,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Tharaud Micka?l&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Tharaud Micka?l,</a> <a href="/journal-foreign-19011/" target="_blank" rel="nofollow" class="tuijian_authcolor">Angewandte Chemie .</a> <span>2020</span><span>,第18期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:癌症激活化疗和光动力疗法结合抗癌癌的多作用和多目标ruii-PTIV缀合物</span> </p> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704027904800.html">Drug delivery micelles with efficient near-infrared photosensitizer for combined image-guided photodynamic therapy and chemotherapy of drug-resistant cancer</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Shijie Zhen&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Shijie Zhen,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Xiaoqing Yi&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Xiaoqing Yi,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Zujin Zhao&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Zujin Zhao,</a> <a href="/journal-foreign-14829/" target="_blank" rel="nofollow" class="tuijian_authcolor">Biomaterials .</a> <span>2019</span><span>,第期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:药物递送胶束,具有高效的近红外光敏剂,用于组合图像引导的光动力治疗和耐药性癌症化疗</span> </p> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/070402648900.html">Multifunctional HER2-Antibody Conjugated Polymeric Nanocarrier-Based Drug Delivery System for Multi-Drug-Resistant Breast Cancer Therapy</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Raju Vivek&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Raju Vivek,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Ramar Thangam&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Ramar Thangam,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Varukattu NipunBabu&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Varukattu NipunBabu </a> <a href="/journal-foreign-18786/" target="_blank" rel="nofollow" class="tuijian_authcolor">ACS applied materials & interfaces .</a> <span>2014</span><span>,第9期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:多功能HER2抗体结合聚合物纳米载体的多药耐药乳腺癌药物输送系统。</span> </p> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/academic-conference-foreign_meeting-269202_thesis/0705015199514.html">Multi-targeted Combinations of Liposomal Drugs for Cancer Chemotherapy</a> <b>[C]</b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Theresa M. Allen&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Theresa M. Allen,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Elaine H. Moase&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Elaine H. Moase </a> <a href="/conference-foreign-269202/" target="_blank" rel="nofollow" class="tuijian_authcolor">Polymeric Materials: Science Engineering Symposia .</a> <span>2010</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:脂质体药物癌症化疗的多目标组合</span> </p> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-degree-foreign_mphd_thesis/02061661612.html">Integrating genomics and molecular biology: identifying transcriptional targets for the prostate cancer oncogene SOX4 and evaluating the efficacy of Aurora kinase inhibition in chemotherapy-resistant ovarian cancer</a> <b>[D] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Scharer, Christopher D.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Scharer, Christopher D. </a> <span>2009</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:整合基因组学和分子生物学:鉴定前列腺癌致癌基因SOX4的转录靶标并评估Aurora激酶抑制作用对化疗耐药的卵巢癌的疗效</span> </p> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-journal-foreign-pmc_detail_thesis/040006831193.html">Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Jianqin Wan&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Jianqin Wan,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Lingling Huang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Lingling Huang,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=Jiangting Cheng&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Jiangting Cheng,</a> <span>2021</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:平衡适应性纳米粒子的稳定性和药物激活增强抗性癌症化疗的增强化疗</span> </p> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/open-access_resources_thesis/01000124525138.html">FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=K. Moore&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">K. Moore,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=A. Oza&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">A. Oza,</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=N. Colombo&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">N. Colombo,</a> <span>2019</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:向前i(GOG 3011):植物毒性α(FRA)叶酸受体α(FRA)的叶酸受体α(FRA),患者(PTS)与铂卵巢癌(PROC)的化疗(PROC)的研究III研究</span> </p> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/academic-journal-cn_journal-guangdong-medical-college_thesis/0201244155106.html">癌症化疗中拉米呋啶抗乙肝病毒重激活的作用</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=黄唯&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 黄唯</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=王安&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,王安</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=陈渝萍&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,陈渝萍</a> <span> <a href="/journal-cn-6482/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 广东医学院学报 </a> </span> <span> . 2009</span><span>,第005期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/academic-journal-cn_journal-dalian-university_thesis/0201235212454.html">熊果酸和齐墩果酸D-苯甘氨酸缀合物的合成、表征及抗癌活性研究</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=房立杰&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 房立杰</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=崔洪光&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,崔洪光</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=赵春晖&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,赵春晖</a> <span> <a href="/journal-cn-3920/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 大连大学学报 </a> </span> <span> . 2013</span><span>,第006期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/academic-journal-cn_chinese-journal-synthetic-chemistry_thesis/0201234473408.html">内盐式磷酯替加氟缀合物的合成与抗癌活性</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=张尊英&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 张尊英</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=刘少琼&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,刘少琼</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=臧中林&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,臧中林</a> <span> <a href="/journal-cn-11569/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 合成化学 </a> </span> <span> . 2007</span><span>,第002期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/academic-journal-cn_henan-science-technology-first-half-month_thesis/0201295300039.html">《科学》癌症特刊:向癌宣战40年 抗癌之路仍漫漫——要研制出更强有力的癌症治疗方法,最重要的是投资和长期努力</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . </a> <span> <a href="/journal-cn-50520/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 河南科技 </a> </span> <span> . 2011</span><span>,第4期</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-journal-cn_laboratory-medicine-clinic_thesis/0201237576440.html">核苷类似物结合肝动脉化疗栓塞术对乙型肝炎病毒再激活的研究</a> <b>[J]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=张晶芬&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 张晶芬</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=付广双&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,付广双</a> <span> <a href="/journal-cn-12698/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 检验医学与临床 </a> </span> <span> . 2018</span><span>,第004期</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-conference-cn_meeting-25058_thesis/020221293920.html">磷脂核苷缀合物CPLT的构型测定及抗癌活性</a> <b>[C]</b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=朱元元&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 朱元元</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=王洪根&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,王洪根</a> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=陈茹玉&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,陈茹玉</a> <span> <a href="/conference-cn-25058/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 2005年全国药物化学会议 </a> <span> <span> . 2005</span> </span> </div> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/academic-degree-domestic_mphd_thesis/020313613035.html">化疗药物联合光动力疗法对人宫颈癌Hela细胞杀伤作用的研究</a> <b>[A] </b> <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=王兆婧&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 王兆婧</a> <span> . 2011</span> </span> </div> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/patent-detail/06120101546192.html">用于癌症选择性标记和靶向的触发器可激活的糖缀合物</a> <b>[P]</b> . <span> 中国专利: CN110520161A </span> <span> . 2019-11-29</span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/patent-detail/06120101481915.html">供治疗癌症的方法中使用的白介素-2免疫缀合物,CD40激动剂,和任选地PD-1轴结合拮抗剂</a> <b>[P]</b> . <span> 中国专利: CN110505883A </span> <span> . 2019-11-26</span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/patent-detail/06130409498891.html">cancer growth or a cancer symptom relief method, chemotherapy drug cancer sensitization method, radiotherapy cancer sensitization method, and therapeutic meal package to provide meals for a cancer patient who retards cancer growth and intensifies the effectiveness of chemotherapy drugs</a> <b>[P]</b> . <span> 外国专利: <!-- --> BR112012009423A2 </span> <span> . 2017-06-13</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:癌症生长或癌症症状缓解方法,化疗药物癌症致敏方法,放疗癌症致敏方法以及治疗性膳食套餐,为癌症患者提供可延缓癌症生长并增强化疗药物有效性的膳食 </span> </p> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/patent-detail/06130404578356.html">Metabolically-activated drug conjugates to overcome resistance in cancer therapy</a> <b>[P]</b> . <span> 外国专利: <!-- 美国专利: --> US10300070B2 </span> <span> . 2019-05-28</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:代谢激活的药物结合物可克服癌症治疗中的耐药性 </span> </p> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/patent-detail/06130408160773.html">METABOLICALLY-ACTIVATED DRUG CONJUGATES TO OVERCOME RESISTANCE IN CANCER THERAPY</a> <b>[P]</b> . <span> 外国专利: <!-- 欧洲知识产权局专利: --> EP3122376A4 </span> <span> . 2017-12-20</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:代谢激活的药物会克服癌症治疗中的耐药性 </span> </p> </li> </ul> </div> </div> </div> <div class="theme cardcommon" style="overflow: auto;display:none"> <h3 class="all_title" id="enpatent55">相关主题</h3> <ul id="subject"> </ul> </div> </div> </div> </div> <div class="right rightcon"> <div class="details_img cardcommon clearfix" style="margin-bottom: 10px;display:none;" > </div> </div> </div> <div id="thesis_get_original1" class="downloadBth" style="bottom: 19px;z-index: 999;" onclick="ywcd('0704028160783','4',7,2,1,'',this,24)" class="delivery" prompt="010401" title="通过人工服务将文献原文发送至邮箱" >获取原文</div> <div class="journalsub-pop-up" style="display: none"> <div class="journal-sub"> <h2>期刊订阅</h2> <img src="https://cdn.zhangqiaokeyan.com/img/loginclose.png" alt="关闭" onclick="$('.journalsub-pop-up').hide()"> <p class="pardon">抱歉,该期刊暂不可订阅,敬请期待!</p> <p class="current">目前支持订阅全部北京大学中文核心(2020)期刊目录。</p> <div style="display: flex;margin-top: 69px;justify-content: space-between;"> <div class="no-sub" onclick="$('.journalsub-pop-up').hide()">暂不订阅</div> <div class="other-sub" onclick="continueSub('from=pc-detail')">继续订阅其他期刊</div> </div> </div> </div> <div class="right_btn"> <ul> <li class="gouwuche"> <!-- <a href="javascript:void(0);" onclick="link_analysis('/shoppingcart/auth/list.html',this)">购物车</a>--> </li> <li class="yijian"> <a href="javascript:void(0);" onclick="link_analysis('/mycenter/auth/complaint.html',this)" title="意见反馈">意见反馈</a> </li> <li class="top"> <a href="javascript:scrollTo(0,0);" title="回到顶部">回到顶部</a> </li> <li class="shouye"> <a href="/" title="首页">回到首页</a> </li> </ul> </div> <div class="xllindexfooter"> <div class="xllindexfootercenter"> <div class="xllindexfooterleft left" > <div class="xllindexfooterleftli"> <ul> <li><a href="/about.html" title="关于掌桥">关于掌桥</a></li> <li><a href="/help/helpmap.html" title="资源导航">资源导航</a></li> <li><a href="/help/helpguide.html" title="新手指南">新手指南</a></li> <li><a href="/help/helpcenter.html" title="常见问题">常见问题</a></li> <li><a href="/sitemap.html" title="网站地图">网站地图</a></li> <li><a href="/help/helpcenter.html?type=9" title="版权声明">版权声明</a></li> </ul> </div> <div class="xllindexfooterleft"> <p class="xllindexfooterlefteamil">客服邮箱:kefu@zhangqiaokeyan.com</p> <div class="xllindexfooterlefttcp"> <div class="xllindexfooterpoliceiimg"></div> <div class="xllindexfooterpoliceispan"> <span>京公网安备:11010802029741号 </span> <span>ICP备案号:<a href="https://beian.miit.gov.cn" rel="nofollow" target="_blank" title="ICP备案号">京ICP备15016152号-6</a></span> <span>六维联合信息科技 (北京) 有限公司©版权所有</span> </div> </div> </div> </div> <div class="xllindexfooterright left"> <ul> <li> <p style="font-weight: bold;">客服微信</p> <div></div> </li> <li> <p style="font-weight: bold;">服务号</p> <div></div> </li> </ul> </div> </div> </div> <span id="0704028160783down" data-source="7," data-out-id="D5/d9T3HULE5gHhfeDm+s8XZ9Ifqcf48YjhKVWPhEVkUa7kMNx64KZ2lg66cicTt," data-f-source-id="7" data-title="A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers" data-price="20" data-site-name="" data-transnum="24" style="display:none;"></span> <input type="hidden" value="4" id="sourcetype"> <input type="hidden" value="19011" id="journalid"> <input type="hidden" value="1" id="inyn_provide_service_level"> <input type="hidden" value="https://cdn.zhangqiaokeyan.com" id="imgcdn"> <input type="hidden" value="1" id="isdeatail"> <input type="hidden" value="" id="syyn_indexed_database"> <input type="hidden" value="" id="servicetype"> <input type="hidden" id="pagename" value="A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers"/> <input type="hidden" value="thesis_get_original" id="pageIdentification"> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery-1.12.4.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/lwlh_ajax.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zq.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/common.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery.cookie.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/top.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/login.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/down.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/search.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/newmail.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/searchtype.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/user/regist.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zxs_solor/detail.js?v=5.7.8"></script> <script type="text/javascript" src="https://www.zhangqiaokeyan.com/statistics/static/pagecollection.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/tj.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/sse.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/pushbaidu.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/history.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/util/cookie.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/weipu/weipu.js?v=5.7.8"></script> </body> <script> $(function(){ var weiPuStatus = getCookie('WeiPuStatus'); if(weiPuStatus){ tipWeiPuStatus(weiPuStatus); delCookie('WeiPuStatus'); } getFacetKeywordVoInId(); var sourcetype = $("#sourcetype").val(); var inyn_provide_service_level = $("#inyn_provide_service_level").val(); if((sourcetype ==1||sourcetype==4)&&inyn_provide_service_level!=4){ getJournal(); } }) </script> </html>